Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
341.11
+8.20 (+2.46%)
Streaming Delayed Price
Updated: 11:01 AM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories
< Previous
1
2
3
4
5
6
Next >
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad Laboratories: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
February 15, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Preview: Bio-Rad Laboratories's Earnings
February 14, 2024
Via
Benzinga
Earnings Outlook For Bio-Rad Laboratories
October 25, 2023
Via
Benzinga
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
September 13, 2023
Via
Investor Brand Network
The Latest Analyst Ratings for Bio-Rad Laboratories
August 04, 2023
Via
Benzinga
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
January 23, 2024
S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upside potential for 2024 rally.
Via
Benzinga
Topics
Artificial Intelligence
Economy
Stocks
Exposures
Artificial Intelligence
Interest Rates
US Equities
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
January 02, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Latest Analyst Ratings for Bio-Rad Laboratories
June 16, 2023
Via
Benzinga
Death Cross Looms Over Bio-Rad Laboratories Investors
May 24, 2023
Via
Benzinga
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%).
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
November 24, 2023
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?
October 27, 2023
Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 26, 2023
Via
Benzinga
Bio-Rad Reports Third-Quarter 2023 Financial Results
October 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
Via
Benzinga
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
October 05, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
September 02, 2023
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.
Via
InvestorPlace
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
August 28, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2023 Financial Results
August 03, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Why Are velo Biosciences Stock Is Trading Higher Today?
July 21, 2023
Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO).
Via
Benzinga
Bio-Rad Announces New Share Repurchase Program
July 20, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Publishes Corporate Sustainability Report for 2022
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
June 16, 2023
Via
Benzinga
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
June 01, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
